Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 295.21M | 291.65M | 279.06M | 266.83M | 256.71M | 244.83M |
Gross Profit | 193.78M | 193.71M | 184.04M | 175.68M | 165.68M | 155.49M |
EBITDA | 65.38M | 62.53M | 59.59M | 53.53M | 44.87M | 46.01M |
Net Income | 20.34M | 20.01M | 15.21M | 12.09M | 5.84M | 14.09M |
Balance Sheet | ||||||
Total Assets | 500.15M | 510.77M | 499.94M | 497.74M | 486.75M | 500.31M |
Cash, Cash Equivalents and Short-Term Investments | 90.62M | 97.22M | 71.13M | 53.91M | 51.95M | 46.49M |
Total Debt | 15.89M | 20.17M | 20.25M | 23.32M | 26.18M | 28.48M |
Total Liabilities | 149.58M | 151.41M | 159.19M | 163.68M | 147.73M | 166.25M |
Stockholders Equity | 350.57M | 359.36M | 340.75M | 334.06M | 339.02M | 334.06M |
Cash Flow | ||||||
Free Cash Flow | 45.32M | 29.52M | 35.96M | 26.09M | 17.04M | 17.07M |
Operating Cash Flow | 62.37M | 57.66M | 63.97M | 51.19M | 42.38M | 35.87M |
Investing Cash Flow | -33.34M | -33.97M | -56.60M | -28.39M | -25.72M | -110.41M |
Financing Cash Flow | -23.04M | -4.52M | -13.04M | -23.70M | -6.21M | -20.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $859.59M | 43.59 | 5.81% | 0.42% | 3.50% | 13.99% | |
66 Neutral | 1.42B | -57.01 | -8.07% | ― | 15.31% | 77.02% | |
51 Neutral | 1.05B | -5.57 | -18.04% | ― | -6.71% | -71.40% | |
51 Neutral | 1.44B | -6.83 | -14.58% | ― | -2.57% | 79.86% | |
49 Neutral | 197.05M | -1.85 | -28.81% | ― | 5.55% | -0.99% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
On August 4, 2025, HealthStream announced its second quarter 2025 results, reporting a record revenue of $74.4 million, a 4% increase from the previous year. The company also declared a quarterly cash dividend and highlighted a significant improvement in operating income and net income compared to the second quarter of 2024. Additionally, HealthStream’s Board of Directors authorized a share repurchase program, which was completed in July 2025.